|Bid||287.71 x 800|
|Ask||288.02 x 1000|
|Day's range||284.22 - 290.09|
|52-week range||195.88 - 309.60|
|Beta (5Y monthly)||1.01|
|PE ratio (TTM)||10.69|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||29 Mar 1994|
|1y target est||N/A|
BURLINGTON, N.C., November 18, 2021--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services. Once completed, the transaction will create a strategic footprint for Labcorp to partner with pharmaceutical and biotechnology clients in the Boston, Mass., area and bolster its strong nonclinical development portfolio.
BURLINGTON, N.C. & NEW YORK, November 04, 2021--Labcorp (NYSE: LH), a leading global life sciences company, and the National Kidney Foundation (NKF), the largest patient organization dedicated to the prevention and treatment of kidney disease, announced their collaboration to promote the NKF Patient Network, the first national registry for chronic kidney disease (CKD) patients in the U.S. The NKF Patient Network will offer greater data and insights to physicians, as well as improved clinical tri
BURLINGTON, N.C., November 02, 2021--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of its executive management team will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, Nov. 9 at 1:00 p.m. ET.